RE: REMDESIVIR USA24 Jul 2020 16:34
A cursory glance at the Remdesivir data shows a modest benefit for recovery times. A slightly more in depth look and you will see that the Remdesivir arm consisted of younger and less comorbid patients... There is no convincing evidence for this drug in humans for any coronavirus. The hype, US hoarding, and current share price are entirely unwarranted. Strong sell for me.